| Metric | Value (₹ Cr) | vs Q1 FY26 |
|---|---|---|
| Revenue | 537.47 | 8.3% |
| Total Income | 552.79 | 9.2% |
| Expenditure | 440.74 | 3.6% |
| PBT | 112.05 | 38.8% |
| Net Profit | 83.84 | 38.7% |
| OPM | 27.13% | 2.77pp |
| NPM | 15.17% | 3.23pp |
| EPS | 4.01 | 38.3% |
Sai Life Sciences Ltd Reports 1,734.62% YoY Profit Growth in Q2 FY2026
06 Nov 2025 · 6 Nov 2025, 08:23 pm
Summary
Sai Life Sciences Ltd has reported a profit growth of 1,734.62% YoY in Q2 FY2026. The company's revenue from operations for the quarter ended on 30 September 2025 was 5,266.69 million, compared to 4,830.38 million in the same period last year. The profit before tax was 1,108.71 million, and the profit for the period was 1,413.19 million.
Key Highlights
- 1
1,734.62% YoY profit growth in Q2 FY2026
- 2
Revenue from operations: 5,266.69 million (Q2 FY2026), 4,830.38 million (Q2 FY2025)
- 3
Profit before tax: 1,108.71 million (Q2 FY2026)
- 4
Profit for the period: 1,413.19 million (Q2 FY2026)
Informational and educational content only. Not investment advice.